- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Non Small Cell Lung Carcinoma
Total 18545 results
-
Konkuk University Medical CenterHanmi Pharmaceutical Company LimitedCompletedNon Small Cell Lung CancerKorea, Republic of
-
Carevive Systems, Inc.CompletedNon Small Cell Lung CancerUnited States
-
Yong FangZhejiang Cancer Hospital; Zhejiang Provincial People's Hospital; Ningbo No. 1... and other collaboratorsUnknownAnlotinib Combined With Docetaxel Versus Docetaxel for Previous Treated Advanced NSCLC (ACWDVDFPTAN)Non-small Cell Lung CancerChina
-
AstraZenecaCompletedNon Small Cell Lung CancerUnited States, Belgium, France, Italy, Spain, Canada, Brazil, Hungary, Peru, Czechia, Bulgaria, Mexico
-
Hanmi Pharmaceutical Company LimitedCompletedNon Small Cell Lung CancerKorea, Republic of
-
Ethicon Endo-SurgeryCompletedNon-small Cell Lung CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.UnknownNon Small Cell LungChina
-
The Catholic University of KoreaUnknownNon-small Cell Lung CancerKorea, Republic of
-
Gustave Roussy, Cancer Campus, Grand ParisAstraZenecaCompletedNon Small Cell Lung CancerFrance
-
Fudan UniversityUnknown
-
Maastricht Radiation OncologyUniversity of PennsylvaniaCompletedNon Small Cell Lung CancerNetherlands
-
AstraZenecaParexelWithdrawnNon Small Cell Lung CancerItaly, Russian Federation, Spain, China, Netherlands, United States, Taiwan, France, Germany
-
Sun Yat-sen UniversityCyttel Biosciences Inc.UnknownNon Small Cell Lung CancerChina
-
Betta Pharmaceuticals Co., Ltd.CompletedNon-small Cell Lung CancerChina
-
Peking Union Medical College HospitalUnknownNon Small Cell Lung CancerChina
-
University of Wisconsin, MadisonTerminatedNon Small Cell Lung CancerUnited States
-
University Hospital, AntwerpAstraZeneca; Universiteit AntwerpenCompletedNon Small Cell Lung CancerBelgium
-
National University Hospital, SingaporeEli Lilly and CompanyCompleted
-
Radiotherapy Oncology Centre "Santa Maria" HospitalPaola Anselmo,MD; Michelina Casale,PhD; Ernesto Maranzano,MD; Fabio Trippa,MDCompletedLocally Advanced Lung Non-Small Cell CarcinomaItaly
-
GlaxoSmithKlineTerminated
-
TheRas, Inc., d/b/a BridgeBio Oncology TherapeuticsRecruitingNSCLC | Metastatic Lung Cancer | Non-small Cell Lung Cancer | Advanced Lung Carcinoma | Metastatic Non-Small Cell Lung Cancer | KRAS G12CUnited States, Australia
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedSmall Cell Lung Carcinoma | Non-Small Cell Lung CarcinomaUnited States
-
National Cancer Institute (NCI)NRG OncologyTerminatedStage IIIA Non-Small Cell Lung Cancer AJCC v7 | Stage III Non-Small Cell Lung Cancer AJCC v7 | Stage IIIB Non-Small Cell Lung Cancer AJCC v7United States
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)M.D. Anderson Cancer CenterTerminatedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)TerminatedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)Active, not recruitingRefractory Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer AJCC v8United States
-
Peking University People's HospitalNational Natural Science Foundation of ChinaCompletedCarcinoma | Lung Neoplasms | Non-small-cell Lung CancerChina
-
Eckhard PodackWithdrawnNon-Small Cell Lung Cancer | NSCLC | Lung Cancer | Non-small-cell Lung Carcinoma
-
Jules Bordet InstituteCompletedMetastatic Melanoma | Colorectal Cancer Metastatic | Metastatic Non-Small Cell Lung CarcinomaBelgium
-
Ohio State University Comprehensive Cancer CenterCompletedLung Non-Small Cell Carcinoma | Lung Small Cell CarcinomaUnited States
-
Lawson Health Research InstituteRecruitingNon-small Cell Lung Cancer Stage IB (Resectable) | Non-small Cell Lung Cancer Stage II (Resectable) | Non-small Cell Lung Cancer Stage ⅢA (Resectable)Canada
-
Bristol-Myers SquibbActive, not recruitingNon-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerAustralia, Russian Federation, United States, Argentina, Austria, Belgium, Brazil, Chile, France, Germany, Ireland, Italy, Mexico, Netherlands, Poland, Romania, Spain, Switzerland, United Kingdom
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyCompletedNon-small Cell Lung Cancer | Advanced Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung CancerUnited States
-
Luye Pharma Group Ltd.UnknownNon Small Cell Lung Cancer | Non Small Cell Lung Cancer Metastatic | Non Small Cell Lung Cancer RecurrentChina
-
City of Hope Medical CenterOSI PharmaceuticalsCompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
Neelesh Sharma MD PhDCompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnRecurrent Non-small Cell Lung Cancer | Stage IA Non-small Cell Lung Cancer | Stage IB Non-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)TerminatedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
Shanghai JMT-Bio Inc.Not yet recruitingSquamous Cell Non-small Cell Lung Cancer
-
Bristol-Myers SquibbCompletedSquamous Cell Non-small Cell Lung CancerUnited States, France, Chile, Australia, Netherlands, Argentina, Austria, Canada, Czechia, Germany, Hungary, Ireland, Italy, Mexico, Norway, Peru, Poland, Romania, Russian Federation, Spain, United Kingdom
-
Novartis PharmaceuticalsRecruitingNon-Small-Cell Lung CarcinomaKorea, Republic of